RARESIGHT Trademark

Trademark Overview

On Monday, July 28, 2025, a trademark application was filed for RARESIGHT with the United States Patent and Trademark Office. The USPTO has given the RARESIGHT trademark a serial number of 99307099. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 28, 2025. This trademark is owned by Raresight, Inc.. The RARESIGHT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical research services in the field of ophthalmic diseases; pharmaceutical product development; research and development services of new pharmaceutical products
raresight

General Information

Serial Number99307099
Word MarkRARESIGHT
Filing DateMonday, July 28, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, July 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical research services in the field of ophthalmic diseases; pharmaceutical product development; research and development services of new pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRaresight, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, July 28, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, July 28, 2025NEW APPLICATION ENTERED
Monday, July 28, 2025APPLICATION FILING RECEIPT MAILED
Monday, July 28, 2025TEAS VOLUNTARY AMENDMENT RECEIVED

Related Keywords

raresight pharmaceutical development services research product products ophthalmic field diseases